Carterra

Content by Carterra

|2 min read

Carterra® Announces Successful Immunity Monitoring of COVID-19 Patients Using a SARS-CoV-2 Label-Free Assay

A new SARS-CoV-2 spike protein biosensor chip was successfully deployed for simultaneous measurements of IgG, IgA, and IgM using only 2 µl of serum per patient
Page 1 of 1